UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000007113
Receipt number	R000008381
Scientific Title	Evaluation of efficacy and safety of combinationtherapy with trastuzumab and eribulin for HER2-positive inoperableness or metastatic breast cancer
Date of disclosure of the study information	2013/12/31
Last modified on	2012/01/22 11:30:44

---